毒素A型对具有神经病变特征的眼睛疼痛的影响
Elyana V T Locatelli1, Jaxon J Huang1, Jason D Betz2
1Surgical and Research Services, Miami Veterans Administration Medical Center, 1201 NW 16th St, Miami, FL, 33125, USA; Bascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.
甲型玻尿素毒素 (BoNT-A) 有效改善了大多数患者的神经病变/鼻膜性眼痛 (NOP) 和生活质量. 纤维肌痛预测了更好的结果,而射击疼痛预测了更糟糕的结果.
科学领域:
- 眼科医生 眼科 眼科
- 神经学 神经学
- 疼痛管理 疼痛管理
背景情况:
- 神经病变/鼻膜性眼睛疼痛 (NOP) 是一个复杂的挑战,尽管常规干眼治疗,但经常持续存在.
- 了解NOP的治疗疗效和预测因素对于改善患者的治疗结果至关重要.
研究的目的:
- 评估毒素A型 (BoNT-A) 在治疗神经病变/鼻膜性眼睛疼痛 (NOP) 的有效性.
- 确定患者特异性因素,预测NOP的BoNT-A治疗后的成功结果.
主要方法:
- 对那些至少接受过一次BoNT-A注射的NOP症状患者进行了回顾性分析.
- 结果,包括疼痛改善和生活质量,在注射后4-6周被评估.
- 分析了人口统计和临床数据,以确定治疗反应的预测因素.
主要成果:
- 74%的患者经历了BoNT-A注射后的疼痛改善,有不同程度的缓解.
- 59%的患者报告生活质量的改善,响应者 (80%) 的改善明显高.
- 纤维肌痛的存在预测了更好的反应,而射击疼痛预测了对BoNT-A的更糟糕反应.
结论:
- BoNT-A在缓解眼睛疼痛和提高NOP患者的生活质量方面表现出显著的有效性.
- 特定因素,包括纤维肌痛和疼痛特征的存在,可以预测治疗反应.
- 这些发现可以指导针对NOP管理的个性化治疗策略.
更多相关视频
05:38Author Spotlight: Utilizing Infraorbital Nerve Ligation in Mice for Investigating Trigeminal Neuropathic Pain and Treatment Strategies
Published on: March 8, 2024
07:39Assessment of Nerve Injury-Induced Mechanical Hypersensitivity in Rats Using an Orofacial Operant Pain Assay
Published on: July 26, 2022
相关概念视频
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Glaucoma: Overview
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
